CD274 and neoplasm: The DCs present the antigens to T cells to prime and activate the T cells using co-stimulatory (CD28, CD80, CD86) and co-inhibitory molecules (PD-L1, CTLA4), to regulate the tumor-specific T cells and encourage the T cells to become effector cells (101).